 This was a prospective randomized, double-blind, multicenter safety and efficacy trial. Patients were stratified by presence or absence of medically treated diabetes mellitus and vessel diameter 3.0 mm or 3.0 mm, then randomized 1:1 to receive either the TAXUS Stent or a Control stent. Additional study stents were permitted to optimize outcomes. The study was considered complete with regard to the primary endpoint after all patients enrolled had completed the 9 month follow-up. 